In this regard, this study provides epidemiologic and mechanistic evidence indicating that the loss of Cav-1 expression promotes a form of metabolism that is permissive to breast cancer progression and, therefore, can negatively impact patient outcome. The gene discussed is CAV1; the disease is breast cancer.